Sort
85,873 grants matching “alzheimers”
TAUOPATHIES: GENOTYPE AND PHENOTYPE
$1,292,648University Of Pennsylvania · P01 · FY2004 · AG
INVESTIGATIONAL NEW DRUG TOXICOLOGY FOR DRUGS TO TREAT ALZHEIMER'S DISEASE AND O
$1,292,488Karen Steinmetz · · N01 · FY2007 · AG
Project 1 -- MIDUS Survey Project
$1,292,364Carol D. Ryff · University Of Wisconsin-Madison · U19 · FY2024 · AG
Connectome 2.0: A BRAIN Technology Integration and Dissemination Resource for Ultra-High Gradient Magnetic Resonance Imaging of Human Brain Circuits Across Scales
$1,292,279Susie Yi Huang · Massachusetts General Hospital · U24 · FY2025 · NS
Development of Therapeutic Antibody for Traumatic Brain Injury
$1,292,237Kun Ping Lu · Beth Israel Deaconess Medical Center · U01 · FY2018 · NS
Adult Changes in Thought (ACT) Research Program Core A: Administrative Core
$1,292,163Katierose Johnson · Kaiser Foundation Research Institute · U19 · FY2025 · AG
Adult Changes in Thought (ACT) Research Program Core C: Life Course Core
$1,292,162Sarah Elizabeth Tom · Kaiser Foundation Research Institute · U19 · FY2025 · AG
Adult Changes in Thought (ACT) Research Program Core D: Neuropathology Core
$1,292,162Christopher D Keene · Kaiser Foundation Research Institute · U19 · FY2025 · AG
Adult Changes in Thought (ACT) Research Program Core B: Clinical Core
$1,292,162Linda Kathleen McEvoy · Kaiser Foundation Research Institute · U19 · FY2025 · AG
Adult Changes in Thought (ACT) Research Program Core F: Data and Analysis Core
$1,292,162Rod Walker · Kaiser Foundation Research Institute · U19 · FY2025 · AG
Cognitively Defined Alzheimer's Subgroups: Natural history, neuropathology, and life course ramifications
$1,292,161Paul K Crane · Kaiser Foundation Research Institute · U19 · FY2025 · AG
Physical activity, sedentary behavior, and sleep in the ACT cohort: The 24-hour activity cycle
$1,292,161Dori Rosenberg · Kaiser Foundation Research Institute · U19 · FY2025 · AG
Translational pharmacoepidemiology: neuroprotection and neurotoxicity of antihypertensives and strong anticholinergics
$1,292,161Shelly L Gray · Kaiser Foundation Research Institute · U19 · FY2025 · AG
Adult Changes in Thought (ACT) Research Program Core A: Administrative Core
$1,291,919Katierose Johnson · Kaiser Foundation Research Institute · U19 · FY2022 · AG
The neuronal stress response in neurodegenerative disease and pain
$1,291,872Claire Le Pichon · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD
Mechanisms of Aging in the Olfactory System
$1,291,602Charles A Greer · Yale University · P01 · FY2009 · AG
Personality and Health: A Longitudinal Study
$1,291,553Grant Edmonds · Oregon Research Institute · R01 · FY2020 · AG
Automated Contact Tracing System for Rapid High-Accuracy Assessment to Management Dementia Patients and Staff Exposed to Infectious Diseases in Long Term Care Facilities
$1,291,484Suneel Ismail Sheikh · Aster Labs, Inc. · R44 · FY2022 · AG
Pacific Northwest Udall Center
$1,291,455Thomas J Montine · University Of Washington · P50 · FY2014 · NS
National Social Life, Health and Aging Project: Baby Boom Cohort Wave 2
$1,291,423Linda J Waite · National Opinion Research Center · R01 · FY2019 · AG
AIM-AI: an Actionable, Integrated and Multiscale genetic map of Alzheimer's disease via deep learning
$1,291,066Zhongming Zhao · University Of Texas Hlth Sci Ctr Houston · U01 · FY2024 · AG
Development and Commercialization of a Tau Oligomer Inhibitor for AD/RD
$1,290,570James G. Moe · Oligomerix, Inc · R44 · FY2021 · AG
Development of an Innovative Vervet (Chlorocebus aethiops sabaeus) Model of Early Alzheimer's-like Neuropathology and Symptomatology
$1,290,401Carol A. Shively · Wake Forest University Health Sciences · R24 · FY2024 · AG
AGING DISEASE--TRANSGENIC/VIROLOGIC/IMMUNOLOGIC STUDIES
$1,289,807Scripps Research Institute · P01 · FY2003 · AG
Neuropeptides and Carboxypeptidase E/ Neurotrophic Factor-1 in Neural and Cognitive Functions
$1,289,713Yoke Peng Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD